FBL promotes cancer cell resistance to DNA damage and BRCA1 transcription via YBX1

EMBO Rep. 2023 Sep 6;24(9):e56230. doi: 10.15252/embr.202256230. Epub 2023 Jul 25.

Abstract

Fibrillarin (FBL) is a highly conserved nucleolar methyltransferase responsible for methylation of ribosomal RNA and proteins. Here, we reveal a role for FBL in DNA damage response and its impact on cancer proliferation and sensitivity to DNA-damaging agents. FBL is highly expressed in various cancers and correlates with poor survival outcomes in cancer patients. Knockdown of FBL sensitizes tumor cells and xenografts to DNA crosslinking agents, and leads to homologous recombination-mediated DNA repair defects. We identify Y-box-binding protein-1 (YBX1) as a key interacting partner of FBL, and FBL increases the nuclear accumulation of YBX1 in response to DNA damage. We show that FBL promotes the expression of BRCA1 by increasing the binding of YBX1 to the BRCA1 promoter. Our study sheds light on the regulatory mechanism of FBL in tumorigenesis and DNA damage response, providing potential therapeutic targets to overcome chemoresistance in cancer.

Keywords: BRCA1; DNA damage repair; FBL; YBX1; colon cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents* / therapeutic use
  • BRCA1 Protein / genetics
  • Cell Line, Tumor
  • Chromosomal Proteins, Non-Histone / metabolism
  • DNA Damage
  • Humans
  • Neoplasms* / metabolism
  • Y-Box-Binding Protein 1 / genetics
  • Y-Box-Binding Protein 1 / metabolism

Substances

  • fibrillarin
  • Chromosomal Proteins, Non-Histone
  • Antineoplastic Agents
  • YBX1 protein, human
  • Y-Box-Binding Protein 1
  • BRCA1 protein, human
  • BRCA1 Protein

Associated data

  • GEO/GSE205366